William Shepard, a director atCME Group (CME), recently bought 1,390 shares. The buy increased his position by 1 percent, and came to a total cost of $281,368. The director was also a buyer in late December, acquiring 278 shares at a cost just under $59,000. Over the past year, the director has made a number of other insider buys, even as other company directors and officers have been regular and consistent sellers of CME shares. Overall, CME Group insiders own 0.4 percent of shares. The owner and operator of a number of global stock and commodity exchanges rose 15 percent in the ...

James Ayers, a major holder ofFB Financial Corporation (FBK), recently added 2,000 shares. The buy increased his holdings by less than 1 percent, and came to a total cost of $70,580. Ayers was the last insider buyer with a 6,500 share pickup last August, totaling just under $199,000. Ayers made a dozen buys last year. Two company directors have also bought shares in the past year, with one of them spending just over $401,000 in total. Overall, FB Financial insiders own 25.2 percent of shares. The Tennessee-based regional bank has traded flat over the past year, underperforming the...

Berkshire Hathaway (BRK-A), a major holder ofLiberty SiriusXM Group (LSXMA) recently added over 2.7 million shares in two transactions. The buy increased the company’s position by 10 percent, and came to a total cost near $85 million. That’s the first insider buy since August, when the company’s Chairman bought 140,000 shares for just under $5 million. Otherwise, there have been a few insider sales, including multiple company directors and the CEO. Overall, Liberty insiders own over 10.2 percent of shares, and Berkshire owns over 22.5 million shares, or nearly 25 percent of the company’s...

Thomas McHugh, CFO atAvadel Pharmaceuticals (AVDL), recently bought 2,000 shares. The buy increased his position by 3 percent, and came to a total cost of $29,000. The CFO was the last insider buyer with a 2,000 share pickup last August. Other company insiders, including multiple directors and the CFO have been buyers. One director with a large stake has been a seller in the past year. Overall, Avadel insiders own 4.3 percent of shares. The biopharmaceutical company has jumped 120 percent higher in the past year amid a promising Phase 3 testing for a narcolepsy drug. Plus, inve...

Paul Livek, a director atRed Violet (RDVT), recently added 4,900 shares. The buy increased his stake by 115 percent, and came to a total cost of $90,174. This is the first insider buy since last May, when a different director bought 2,000 shares, paying just under $49,000 to increase her stake by about 70 percent. Otherwise, a major holder sold 10,000 shares, netting about $250,000 for doing so. Overall, Red Violet insiders own about 33.7 percent of shares. The identity intelligence company is down about 25 percent over the last year. That’s despite a 5 percent increase in revenue...

Avijit Ray-Chaudhuri, an EVP atAehr Test Systems (AEHR), recently bought 3,000 shares. The buy increased his stake by 45 percent, and came to a total cost of $53,600. This marks the first insider activity of the year. It’s the first insider buy since October, when a company director bought 700 shares. Otherwise, company insiders have been steady sellers of shares over the past year. Only a small fraction of the sales came from the exercise of stock options. Overall, Aehr Test Systems insiders own 5.7 percent of shares. The semiconductor testing solutions company is down nearly 40 ...

Fund 1 Investments, a major holder ofTilly’s (TLYS), recently bought 130,302 shares. The buy increased the fund’s position by 2 percent, and came to a total cost of $936,186. This marks the fund’s first buy of the year. The fund was heavily active throughout 2023, buying shares steadily over a dozen times. The company’s CFO also bought 3,400 shares last year, paying just over $21,000 to do so. And two directors made small sales. Overall, Tilly’s insiders own 2.5 percent of shares. Institutional holders own nearly all the float. The specialty clothing retailer is down 20 percent ov...

Richard Agree, Chairman ofAgree Realty (ADC), recently bought 10,500 shares. The buy increased his stake by 2 percent, and came to a total cost of $656,985. That’s the first insider buy of the year. 2023 saw over two dozen insider buys, including a buy from Richard Agree valued at over $1.1 million. Company directors and executives alike picked up shares last year. And there were no insider sales. Overall, Agree Realty insiders own 1.6 percent of shares. The retail-oriented real estate investment trust dropped 17 percent over the past year, amid a weak retail environment and risin...

Broadwood Partners, a major holder atSTAAR Surgical Company (STAA), recently added 226,553 shares. The buy increased the fund’s position by 1 percent, and came to a total cost of $6.48 million. This marks the first insider activity since December, when a company director bought 850 shares for a cost of $26,129. Broadwood Partners was active acquiring shares throughout last year as well. The last insider sale occurred in March 2023. Overall, STAAR insiders own 0.7 percent of shares, and institutions own the rest of the outstanding float. The producer of implantable eye lenses saw i...

Steven Downing, a director atVOXX International (VOXX), recently bought 1,568,750 shares. The buy increased his stake by 90 percent, and came to a total cost of $15.69 million. This follows up on a 1.57 million share pickup made by the director back in October. Other company directors have been buyers in the past year, albeit at a far smaller size. On the sell side, the company’s President has been a sizeable seller of shares in recent months. Overall, VOXX insiders own 45.2 percent of shares. The automotive electronics manufacturer rallied 10 percent last year, returning about ha...